[go: up one dir, main page]

MA40417A - Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques - Google Patents

Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques

Info

Publication number
MA40417A
MA40417A MA040417A MA40417A MA40417A MA 40417 A MA40417 A MA 40417A MA 040417 A MA040417 A MA 040417A MA 40417 A MA40417 A MA 40417A MA 40417 A MA40417 A MA 40417A
Authority
MA
Morocco
Prior art keywords
acid
fatty acids
palmitoylethanolamide
inflammatory
mixture
Prior art date
Application number
MA040417A
Other languages
English (en)
Inventor
Carmela Migliaccio
Raffaele Migliaccio
Antonella Sardei
Original Assignee
Raffaele Migliaccio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raffaele Migliaccio filed Critical Raffaele Migliaccio
Publication of MA40417A publication Critical patent/MA40417A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un mélange contenant jusqu'à deux acides gras choisis entre l'acide palmitique, l'acide oléique, l'acide stéarique, l'acide linoléique, l'acide alpha-linolénique, l'acide gamma-linolénique, l'acide eicosapentaénoïque, l'acide docosahexaénoïque, l'acide azélaïque et l'acide myristique, et du palmitoyl éthanolamide. Dans un mode de réalisation de la présente invention ledit mélange est caractérisé en ce qu'au moins l'un desdits acides gras est saturé. La présente invention con
MA040417A 2014-08-08 2015-08-03 Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques MA40417A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20141474 2014-08-08

Publications (1)

Publication Number Publication Date
MA40417A true MA40417A (fr) 2017-06-14

Family

ID=51663273

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040417A MA40417A (fr) 2014-08-08 2015-08-03 Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques

Country Status (13)

Country Link
US (2) US9962355B2 (fr)
EP (1) EP3177281B1 (fr)
JP (3) JP7118642B2 (fr)
CN (1) CN106714792A (fr)
CA (1) CA2957700C (fr)
CO (1) CO2017001088A2 (fr)
DK (1) DK3177281T3 (fr)
ES (1) ES2976095T3 (fr)
FI (1) FI3177281T3 (fr)
IL (1) IL250271B2 (fr)
MA (1) MA40417A (fr)
TW (1) TWI727926B (fr)
WO (1) WO2016020828A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3377067A4 (fr) * 2015-10-07 2019-07-31 Cormedix Inc. Formulation de pénétration cutanée à base de taurolidine
CN109893520A (zh) * 2019-03-21 2019-06-18 中国科学院水生生物研究所 螺旋藻γ-亚麻酸的新用途
AU2020260090C9 (en) 2019-04-15 2023-08-31 Metagenics LLC Novel hemp and PEA formulation and its use
CA3194061A1 (fr) * 2020-09-21 2022-03-24 The Regents Of The University Of California Effets immunologiques de metabolites
IT202100024464A1 (it) * 2021-09-23 2023-03-23 Epitech Group S P A N-palmitoil-etanolamide e acido docosaesaenoico per l’uso nel trattamento del disturbo dello spettro autistico e di altre sindromi depressive
CN114209683A (zh) * 2021-12-22 2022-03-22 中南大学湘雅三医院 壬二酸在制备治疗炎症性肠病药物中的应用
JP2025509604A (ja) 2022-03-14 2025-04-11 フェラ ダイアグノスティックス アンド バイオロジカルズ コーポレーション 脂肪酸組成物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1252865B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni
US5679667A (en) 1992-04-24 1997-10-21 Lifegroup S.P.A. Aminoalcohols-N-Acyl derivatives as therapeutical agents against the neurogenic endoneural edema of the peripheral nerve
IT1257697B (it) * 1992-04-24 1996-02-01 Lifegroup Spa N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
WO1994000127A1 (fr) * 1992-06-19 1994-01-06 The Regents Of The University Of California Lipides pour l'humidification de l'epiderme et la restauration de la fonction de barriere
EP0620000A3 (fr) * 1992-12-18 1994-11-02 Rhone-Poulenc Rorer Gmbh Utilisation cosmétique et/ou pharmaceutique des N-acylalcanolamines
US5599548A (en) * 1995-05-08 1997-02-04 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides and retinol or retinyl ester
US5716627A (en) * 1996-04-25 1998-02-10 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
JP2000159668A (ja) * 1998-11-26 2000-06-13 Nof Corp サイトカイン抑制剤
JP2000191525A (ja) * 1998-12-25 2000-07-11 Nof Corp 皮膚外用剤組成物
GB9923738D0 (en) * 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
US20020143059A1 (en) * 2000-12-28 2002-10-03 Sreekumar Pillai Skin care product containing retinoids, retinoid booster and phytoestrogens in a dual compartment package
DE10217131A1 (de) * 2001-07-31 2003-02-13 Kuhs Kosmetik Gmbh & Co Kg Topisch applizierbare Zusammensetzung sowie Werkstoffgemisch
EP1844784B1 (fr) * 2006-03-28 2010-04-21 Epitech Group S.r.l. Composition pharmaceutique pour le traitement de pathologies causées par une réponse immunitaire
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
HRP20170050T1 (hr) * 2008-02-22 2017-03-10 Rigel Pharmaceuticals, Inc. Uporaba 2,4-pirimidindiamina za liječenje ateroskleroze
DE202008007621U1 (de) * 2008-06-04 2008-11-06 Zimmer, Bruno Kosmetisches und Nahrungsmittel aus unterschiedlichen Fettsäuren
AU2011223730A1 (en) * 2010-03-02 2012-10-18 Imagenetix, Inc. Compositions comprising myristic acid and uses thereof
EP2558474B1 (fr) * 2010-04-13 2015-11-25 Rigel Pharmaceuticals, Inc. Composés 2,4-pyrimidinediamine et leurs promédicaments, et leurs utilisations
ITMI20111284A1 (it) * 2011-07-11 2013-01-12 Giovanni Nusca Composizione farmaceutica.
EP2850062B1 (fr) * 2012-05-18 2017-07-19 Sanofi Derives de pyridine utiles dans le traitement de conditions associees a formation pathologique des thrombes
ITMI20130354A1 (it) * 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
CN103242262A (zh) * 2013-05-24 2013-08-14 厦门大学 N-脂肪酰基乙醇胺水解酶抑制剂及其合成方法和用途

Also Published As

Publication number Publication date
CA2957700C (fr) 2022-12-13
JP7118642B2 (ja) 2022-08-16
IL250271A0 (en) 2017-03-30
TWI727926B (zh) 2021-05-21
IL250271B2 (en) 2023-02-01
CO2017001088A2 (es) 2017-04-28
US20170224645A1 (en) 2017-08-10
EP3177281B1 (fr) 2023-12-06
BR112017002474A2 (pt) 2017-12-05
JP2023041806A (ja) 2023-03-24
CN106714792A (zh) 2017-05-24
CA2957700A1 (fr) 2016-02-11
IL250271B (en) 2022-10-01
US20180243254A1 (en) 2018-08-30
US10149827B2 (en) 2018-12-11
US9962355B2 (en) 2018-05-08
JP2021004260A (ja) 2021-01-14
JP7335475B2 (ja) 2023-08-30
FI3177281T3 (fi) 2024-03-13
WO2016020828A1 (fr) 2016-02-11
DK3177281T3 (da) 2024-03-11
ES2976095T3 (es) 2024-07-23
JP2017523230A (ja) 2017-08-17
TW201609084A (zh) 2016-03-16
EP3177281A1 (fr) 2017-06-14

Similar Documents

Publication Publication Date Title
MA40417A (fr) Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques
MY165048A (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
CY1122248T1 (el) Μιγμα λιπαρων οξεων προς χρηση στη θεραπευτικη αγωγη φλεγμονωδων παθολογιων
ZA201704820B (en) Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
MX2016004487A (es) Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.
SG11201705938TA (en) SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID
PH12014500105A1 (en) Fatty acid compositions
ZA201704821B (en) Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids
GEP201606568B (en) Compositions for the treatment of neurologic disorders
EP3613833C0 (fr) Composition d'acides gras monoinsaturés à longue chaîne et composition d'acides gras polyinsaturés à longue chaîne et son procédé de fabrication
ZA201702385B (en) Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
MX2015011767A (es) Composiciones de aceite crudo de algas.
GB201611497D0 (en) Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids
PL3784044T3 (pl) Kompozycje wielonienasyconych kwasów tłuszczowych wzbogacone w dha
TW201613571A (en) OMWGA-3 compositions, dosage forms, and methods of use
PL3809858T3 (pl) Kompozycje wielonienasyconych kwasów tłuszczowych wzbogacone w dha
PL3560342T3 (pl) Kompozycje wielonienasyconych kwasów tłuszczowych wzbogacone w dha
PL3809860T3 (pl) Kompozycje wielonienasyconych kwasów tłuszczowych wzbogacone w dha
PL3455351T3 (pl) Sposób zwiększania wytwarzania wielonienasyconych kwasów tłuszczowych omega-3 w mikroalgach
GB201611503D0 (en) Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids
GB201611500D0 (en) Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids
GB201611499D0 (en) Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids
HK1232769A1 (en) Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
GB201607617D0 (en) Use of EPA and DHA Omega3 Dietary supplementation and Omega6 polyunsaturated fatty acid dietary restriction to cure 2 type diabetes
AR095832A1 (es) Composición farmacéutica oral útil para el trastorno del déficit de atención e hiperactividad, suplemento nutricional y alimento que la comprenden y proceso para preparar la composición